FDA recall, , Moderate risk
Sun Pharmaceutical Sumatriptan and Naproxen Sodium Tablets
Sumatriptan and naproxen sodium tablets failed a 12-month test of how the medicine dissolves.
What to do
Check yoursIf a code on your package is listed below:
- Don't stop taking it without talking to your pharmacist or doctor; ask them whether your lot is recalled.
Typical advice for a recalled medicine; the FDA notice gives no product-specific instructions.
What happened
Sun Pharmaceutical Industries Inc., of Princeton, New Jersey, is recalling Sumatriptan and Naproxen Sodium Tablets. Testing during stability checks found that the tablets did not meet the quality limits the product must meet. The problem is with how the medicine dissolves, which is the step that lets the body take it in. The company started the recall on its own.
Two bottle versions are affected. One is labeled with the Northstar Healthcase Holdings Ltd. name and includes 3,453 bottles. The other is labeled Sun Pharma and includes 10,296 bottles. Both are 9-count bottles. Customers were told by letter, and the product was distributed nationwide within the U.S. The company began the recall on October 27, 2026, and the FDA classified it on November 18, 2026.
Is yours affected?
Match your product and all the details in one listed combination.
An NDC (National Drug Code) is usually printed on the drug's label.
Sumatriptan and Naproxen Sodium Tablets
- Strength
- 85 mg
- NDC
- 16714-891-01
- Lot code
- DNG0559A
- Recall number
- D-0187-2027
- NDC
- 47335-410-22
- Lot code
- DNG0559B
- Recall number
- D-0186-2027
Recall details
- Posted by FDA
- Recall began
- Status
- Open
- Weekly archive
- Listed the week of Nov 16, 2026
- Sold in
Distributed nationwide.
- Recalled by
- Sun Pharmaceutical Industries IncPrinceton, New Jersey
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- FDA event number
- 100207
- Recall numbers
- D-0186-2027 to D-0187-2027
- Recall type
- Started by the company
- How the company first told customers
- Letter
All recalls from Sun Pharmaceutical Industries Inc
Timeline
FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.
SUN PHARMACEUTICAL INDUSTRIES INC began the recall
FDA posted the recall to its Enforcement Report and rated it Class II (moderate risk)
Added to Recall Canary



